Page-6 of Current Affairs - June, 2014

PSUs have only 3 years to make 25% of their shares public: SEBI

June 24, 2014

With a view to boost primary markets, stock markets watchdog Securities and Exchange Board of India (SEBI) announced a number of reforms pertaining to IPO and Offer-for-Sale. SEBI proposed that all listed PSUs (Public Sector Undertakings) must have at least ..

Month: 

Google to globalize “Project Loon” to provide internet to even the rural and remote areas of the world

June 24, 2014

In year 2013, Google launched Project Loon, a program that intends to provide Internet access to the rural and remote areas that constitute around 66% of the world’s population. The project uses balloons floating at high altitudes that move up ..

Month: 

Category: 

Steel to be dearer by up to Rs 1,000 a tonne

June 24, 2014

The recent 6.5% hike in railway freight rate has led to an increase of Rs 300 a tonne in the prices of steel products across the country. Traders are considering a further increase of Rs 700-1,000 a tone in coming ..

Month: 

Category: 

Obninsk plant: World's 1st nuke power plant turns sixty

June 24, 2014

Obninsk Nuclear Power Plant– world’s first nuclear power plant which epitomized the peaceful use of nuclear technology, particularly during the Cold War era, turned 60 on June 26. The plant is located in a village called Pyatkino in Obninsk city, ..

Month: 

Category: 

Gujarat govt provides 33% quota for women in police force

June 24, 2014

Gujarat CM Anandiben Patel announced 33% quota for women in police force. Though 33% reservation for women in police force already exists but due to stringent criteria for physical tests, the percentage could not be met. The government will adjust those criteria to ..

Month: 

Category: 

India denies patent to US pharmaceutical firm Abraxis BioSciences' anti-cancer drug "Abraxane"

June 24, 2014

The Indian Patent Office (IPO) has denied a patent on US firm Abraxis BioSciences’ anti-cancer drug ‘Abraxane’. The application was rejected on the grounds that the drug lacked invention, not being patentable and insufficient. While rejecting the patent IPO took into account Section ..

Month: 

Category: